Acorda Therapeutics, Inc. (ACOR)
(Delayed Data from NSDQ)
$11.74 USD
+1.16 (10.96%)
Updated May 3, 2019 04:00 PM ET
After-Market: $11.74 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ACOR]
Reports for Purchase
Showing records 101 - 120 ( 440 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for ACOR.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
With Most Of The Fireworks Already Shot Off, Looking For Quiet 4Q20 Reporting
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for ACOR.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker -- Week Ending 1/8/21
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Pre-Announce Ampyra Beat, But Chelsea Divestiture More Important
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for ACOR.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for ACOR.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for ACOR.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker - Week Ending 12/11/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker - Week Ending 11/13/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for ACOR.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker -- Week Ending
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Ampyra Still Leading The Charge For ACOR - Unclear What Will Get Inbrija Moving
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for ACOR.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker - Week Ending 10/23/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L